The difference between information and
expert, data-driven actionable intelligence
Welcome to the September 2015 issue of CMC Market Outlook
This monthly e-newsletter provides valuable insights for both buyers and sellers of CMC drug development services. Our coverage will help you identify and understand market trends that will inform your strategic business perspective.
Enjoy the September issue!
Early Development Services Enjoy Strong First Half
Results from the first half of the year highlighted the importance of external fundraising to drive elements of the outsourcing ecosystem. Contract service providers supporting early development, especially those with a strong presence in drug discovery, posted a revenue increase of 18% on a constant currency basis, led by WuXi Apptec and Charles River Laboratories.
Large and small molecule API manufacturers grew revenues by… read on
New Report Available: PharmSource CMO Industry Analysis
Our just-released 2015 Contract Dose Manufacturing Industry by the Numbers report is an indispensable resource for understanding the competitive environment faced by dose manufacturers, and provides critical insights for your strategic planning efforts. The report will enable you to:
- Benchmark your performance against other CMOs in the industry
- Understand what strategies CMOs are pursuing for profitable growth
- Grasp CMO business challenges affecting bio/pharmaceutical negotiations
Thanks to our deep expertise and ongoing research, Contract Dose Manufacturing Industry by the Numbers is the most authoritative and reliable portrait of the CMO industry available to the bio/pharmaceutical industry today.
Our proprietary model and assumptions are fully explained so you can understand how we arrived at our analysis and conclusions.
You won’t find this mission-critical information in any other source. Click here for more information or to order this report today.
How big is the market for…?
This is a handy guide to frequently requested data about the bio/pharma contract services industry.
The market for innovator API development and manufacturing – outsourced spending:
|2014: $13-15 billion||Cambrex
Presentation at Jefferies 2015 Global Healthcare Conference
Read more about the size of the contract services market for various segments.
PharmSource President Jim Miller
to Speak at Two Industry Events
to Speak at Two Industry Events
Contract Pharma: 14th Annual Conference and Tabletop Exhibition.
New Brunswick, New Jersey
Thursday, September 17 at 2:15pm
CPhI Worldwide: Pharma Insight Briefings.
Wednesday, October 14 at 12pm
PharmSource STRATEGIC ADVANTAGE
PharmSource’s STRATEGIC ADVANTAGE service is the industry’s most respected outsourcing information web portal for serious consumers of information on contract drug development and manufacturing. Developed from PharmSource’s expert proprietary research, you won’t find this information in any other resource.
See for yourself how this resource gives you vital tools for understanding the industry.
To request a test-drive today, contact Nathaniel Celentano at firstname.lastname@example.org / +1-703-383-4903, ext. 112 (ET USA).